Over 70 and on cholesterol medicine? Decide the next step together
Evidence: StrongEveryoneAd-safe topic
A big new trial looked at what happens when adults over 70 without heart disease stop their daily cholesterol medicine, and the answer is a conversation, not a rule.
Hosted video lesson
Coming soon
Our Academy host will teach this lesson on camera. Read it below today.
What the research found
1In a trial of 1,880 adults aged 70 and older (average age 77.5) who took statins to prevent a first heart problem, people who stopped spent an average of 96.5 weeks of the first 2 years free of heart attack, stroke or death, compared with 98.5 weeks for people who kept taking them, a 2-week gap the trial counted as close enough.
2Over a median follow-up of about 2 years, heart attack, stroke or death happened in 12.7% of people who stopped and 9.2% of people who continued, which the researchers put at about 1 extra event for every 40 people who stopped.
3Stopping did not make a clear difference in quality of life, pain, falls or muscle loss risk, so the lead researcher said any decision to stop should come only after shared decision-making with a licensed provider.
The fine print. The trial was open-label with no placebo, some people switched groups during the study, and it was a noninferiority design, so it shows stopping carries a small added risk rather than proving it is safe for everyone. It applies only to adults aged 70 and older in Switzerland, France and the Netherlands who had at least two long-term health conditions and no known heart or blood vessel disease, and nobody should stop a prescribed medicine without talking with their licensed provider first.
Ask a licensed provider
"Given my age, my other health conditions and my goals, what are the benefits and risks of continuing my cholesterol medicine versus stopping it?"
Source: Rodondi N, et al. STREAM trial. N Engl J Med. 2026 (published online Nov 7, 2026; randomized, open-label noninferiority trial, n=1,880; doi:10.1056/NEJMoa2606634). Open the paper
For your business
Share it as a calm carousel for adult children and older members: one slide on what the trial found, one on questions to bring to a licensed provider before changing any daily medicine.
Post-ready caption
Over 70 and on cholesterol medicine? Decide the next step together
What does the research say?
In a trial of 1,880 adults aged 70 and older (average age 77.5) who took statins to prevent a first heart problem, people who stopped spent an average of 96.5 weeks of the first 2 years free of heart attack, stroke or death, compared with 98.5 weeks for people who kept taking them, a 2-week gap the trial counted as close enough. Over a median follow-up of about 2 years, heart attack, stroke or death happened in 12.7% of people who stopped and 9.2% of people who continued, which the researchers put at about 1 extra event for every 40 people who stopped.
The fine print: The trial was open-label with no placebo, some people switched groups during the study, and it was a noninferiority design, so it shows stopping carries a small added risk rather than proving it is safe for everyone. Evidence level: Strong.
Ask a licensed provider: "Given my age, my other health conditions and my goals, what are the benefits and risks of continuing my cholesterol medicine versus stopping it?" Start at hoolongevity.com.
Want your own branded telehealth storefront? HOO Health builds it for you: $0 to start, no sign-up fee, no MLM, no quotas. joinhoohealth.com
Source: Rodondi N, et al. STREAM trial. N Engl J Med. 2026 (published online Nov 7, 2026; randomized, open-label noninferiority trial, n=1,880; doi:10.1056/NEJMoa2606634).
Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary.
#HealthEducation #Healthyaging #Longevity #Wellness #Telehealth #HOOHealth